Your Challenges Require Smart Solutions:
PharmaPharmacelsus - Preclinical ServicesIn vitro & in vivo Pharmacology

In vitro & in vivo Pharmacology

In-depth knowledge

To gain profound and relevant preclinical data on efficacy and potency, in-depth knowledge of the corresponding disease is a key success factor. Pharmacelsus has a proven track record on conducting In vitro and in vivo studies on potency, selectivity and efficacy in several indication areas.

In vitro Pharmacology Assays

5α Reductase Inhibitors

  • Human Recombinant Isoenzymes Type I and II

In vivo Pharmacology Models

Diabetes / Metabolic Syndrome Models

  • Induced Models:
    • STZ Mice/Rats
    • DIO Mice/Rat
  • Genetic Models
    • ob / ob Mice
    • db / db Mice
    • Zucker /ZDF Rat

Cancer

  • In vivo Model
    • (immunodeficient mice)
  • Principle:
    • s.c. tumor xenograft model
  • General Readouts:
    • Tumor incidence, tumor size, tumor growth inhibition, terminal tumor weight, occurrence of metastases (Postmortal)

Leveraging our experience allows us to design, set-up and perform in vitro and in vivo pharmacology studies according to the specific requirements of your project.

Your contact at Pharmacelsus

MUDr. Maria Li
Director Business Development
Mobile: +49 173 889 4288
​Li@pharmacelsus.de

Business Development

Contact us!

To learn more about us and what we can do for you please contact our Director Business Development .

The experienced and highly committed Pharmacelsus team offers a variety of different services the following in Areas.

In vitro ADME

More

In vivo DMPK

In vitro & in vivo Toxicology

G(C)LP & non-GLP Bioanalytics

Biomarker Services

Services for Biologics

Preclinical Services

GBA Group Pharma

STAY IN TOUCH

GBA Group Pharma Newsletter

Always stay up to date and register for our newsletter.

© 2020 GBA Group
Privacy Juridische informatie AVColofon